Abstract
Background. Nowadays, the immunomodulatory properties of plants have been studied extensively with greater interest due to increasing awareness and combating the severity of immunomodulatory diseases. Scope and Approach. This paper highlights the efficacy of the available literature evidence on natural immunomodulators of plant origin and synthetic ones. In addition, several aspects of plants and their phytoconstituents responsible for immunomodulation have been discussed. Moreover, this review also discusses the mechanism involved in immunomodulation. Key Findings. One hundred fifty medicinal immunomodulatory plants are currently identified to find novel immunomodulatory drugs. Of these plants, the plant family Asteraceae also takes the first rank by offering 18 plant species (12%). Similarly of the plants studied so far, 40% belong to the Asteraceae family. Echinacea purpurea of this family is most known for its immunostimulating activity. The most prominent immune-active bioactive molecules are polyphenols, terpenoids, and alkaloids. Also, eight plant bioactive immunomodulators were checked for clinical trials and found in the market. These are six immunosuppressants, resveratrol, epigallocatechin-3-gallate, quercetin, colchicine, capsaicin, and andrographolide, and two immunostimulants, curcumin and genistein. Nowadays, there are a lot of polyherbal traditional medicinal products sold in the market and claimed to their immunomodulators. However, much work is still needed to find more active immunomodulatory agents. The mechanism by which immunomodulatory medicinal plant exert their effect is through the induction of cytokines and phagocyte cells and the inhibition of iNOS, PGE, and COX-2 synthesis.
1. Introduction
Nowadays, in the 21st century, the world health sector is facing different problems. Among the problems faced by the scientific communities are antibiotic resistance [1], antiviral resistance, and anticancer resistance [2], side effects of commercial drugs [3], undeveloped drug delivery mechanism, treatment of cardiovascular disease, metabolic disorder, COVID-19, inflammation, and neurological disorder. The scientific community forecasts that due to only antibacterial resistance, by 2050, ten million people's death is expected [4]. Twenty-two million people's death is also expected by 2030 due to cardiovascular disease [5, 6].
However, despite this burden, the scientific community is also looking for a solution by relying on traditional medical practice knowledge. One of the scientific community's solutions is that disease prevention needs much effort as working on the curing agent [7]. Among the prevention mechanism, which is also stated in the traditional health care system of different parts of the world, enhancing the human immune system is one solution to reduce the increasing incidence of diseases and deaths [8]. Immunotherapies using plant-sourced phytochemicals are now getting attraction to combat the spread of cancer, autoimmune disease, and infection [9].
The second intersection point of agreement between the scientific community and traditional medicinal plant practitioners is that it is good to study and use traditional medicine called natural products since they are multivalent component agents than monovalent commercial drugs [10, 11]. Medicinal plants are the best reservoirs of bioactive compounds. The are less expensive and easily available and have less side effects which make them suitable for producing drugs [12].
According to various traditional medical systems around the world, such as the Indian Ayurvedic system, it is beneficial to increase body resistance. Even in Ayurvedic, one chapter is called “Rasayana” which means plant drug, herbal medicine, traditional, or natural medicine reputed to increase body resistance [13]. Nowadays, it is called immunity-enhancing medicinal plants. These plants, listed under the “Rasayana” chapter, prevent diseases like aging, cancer, diabetes, autoimmune disease (like rheumatoid arthritis), and Parkinson's disease. Like the Indian Ayurvedic, there is a traditional health care system worldwide like those found in Egypt, China, Ethiopia, Western, Kampo (Japan), and Greco-Arab or Unani-Tibb (South Asia) [13].
Despite the traditional health care system, the scientific community clinically classifies immunity enhancement method into three. The first and second are called immunization and taking probiotic food, while the third is called vaccination. Immunization is self-immunity development after exposure to disease. Probiotic foods, for example, fermented foods, cause the development of useful bacteria in the guts and hence improve the human body immune system. For instance, a review study done by [14] indicates that these foods' immunomodulatory activity is because of their rich content of antioxidant and lactic acid-producing bacteria. Besides this, taking appropriate food is also considered as one means of immunity-enhancing methods. For example, a study done by [15] indicates that bell pepper and carrot have a phytochemical called rhamnogalacturonan-I (RG-I) that stimulates innate immune system in our body. However, in general, there are eight immune-enhancing methods for a healthy man to follow [16].
Scientifically, immunity systems are divided into innate immunity and adaptive immunity. Generally, the type of natural medicine and synthetic drugs as immunomodulators, which will be discussed later, is divided into three: immunomodulators, immunosuppressant, and immunoadjuvant [17, 18].
The Medical Herbalism book written by Hoffman in 2003 [19] and the book by Pal and Nayak in 2021 [20] classify the phytochemical immunomodulators into two: low and high molecular weight compounds. Similarly, there are two modes of action by which immunomodulatory compounds exert their effect, namely, specific and nonspecific [19, 20].
Taking immunomodulators is mostly used to boost the immune mechanism in immunocompromised patients and suppress the immune system of those who by autoimmune disease are affected. According to Johns Hopkins University's pathology department website information in the USA, autoimmune diseases affect 3% of the USA population (Figure 1) [21].
Figure 1.

Prevalence of disease report by 2022 in the USA. Adopted from the immunology department of Johns Hopkins University website in 2022.
In addition to autoimmune diseases, immunodeficiency diseases of the first type, primary immunodeficiency disease (PIDD), also affect the world population. Genetic defects of antibodies cause PIDD, and until now, around 130 PIDD types are identified [22]. A systematic global review of PIDD registries from January 1981 to June 2020 published and unpublished studies indicate that 13852 (13.2%) of all registered 104614 PIDD patient molecular defects in genes are identified to cause PIDD. From the total registered PID, approximately 10590 additional PID patients are registered from Asia and Africa [23].
This review highlights the research done on immunomodulators of plant origin and synthetic agents. As introduction, for example, a study done by [24] indicates elderberry plant extract called eldosamb® has the ability to reduce the production of cytokines like TNF-α and IFN-γ and hence cause the initiation of Th2-helper cell, which means adaptive immune system. This product is now available in the market. However, this review also highlights mostly unmarketed plant and plant extract that have immunomodulatory activities.
2. Methods
In this review, scientific journals were selected manually on the Internet using the keywords immunomodulators plant, immunostimulant drug, immunostimulant plant, immunosuppressant drug, and plant as immunomodulators from Scopus, PubMed, Google Scholar, and ScienceDirect.
Hence, 67 journals were collected. Out of the 67 journals, 42 were referred to in addition to the six books and one website of Johns Hopkins University known with pandemic COVID-19 information.
In addition, microbiological professionals were questioned to gain insight more in detail about immunity. To draw the chemical structure of immunomodulatory compounds, ChemDraw version 8 was also used, while EndNote version 6 is used for referencing the Natural Products Database for Africa (NDA) used for botanical name cross-checking. Microsoft Excel is also used for drawing the pie chart.
3. Immunity System
It is a human defense system from endogenous and exogenous chemical and biotic invaders through the physical barrier and robotic electric or molecular reaction communication of specialized cells and organs. The biotic “foreign” invaders are called antigens (microbes—infection-causing organisms such as bacteria, viruses, parasites, and fungi or any injury- and disease-causing agent) [25]. The different organs of the human immune system are shown in Figure 2. The organs include the lymphoid, thymus, and bone marrow. The reason to put this figure is to appreciate our creator, the almighty God. If you look at the diagram, the immune system is located at the sensitive positions, accessible for pathogens to enter our body.
Figure 2.

Organs of the human immune system. Adopted from [26].
When an antigen makes first contact with the cell, the immune system's first action is scanning and recognizing it as self from non-self-substances [27]. Due to cell recognition, the immune system cell recognizes the self-substance as a substance belonging to the host organism. At the same time, non-self-molecules are foreign that do not belong to the host organism. One example of non-self-molecules is antigens that cause the immune system to promote the generation of antibodies against it and then combine specifically with them to induce an immune response. The generation of antibodies is due to cytokine chemicals released from the antigen-presenting cell [28]. Autoimmunity is an immune response opposed to healthy cells and tissues, leading to autoimmune diseases [29].
4. Type of Immunity and Immunity-Related Disorder
Human defense against infection has two primary forms, namely, innate immunity and adaptive immunity (Figure 3). Innate immunity has been considered the first line of defense against pathogens. Innate immunity includes physical barrier (hair, mucus, and skin), chemical substance (salt in the skin and tear in the eye), blood protein, phagocyte cells (macrophages and dendritic cells (DCS), mast cells, neutrophils, basophils, eosinophils, invariant natural killer cells (NK cells, NKT cells, and gd T cells). When innate immune cells and normal cells are combating pathogens, they release a chemical called cytokines. These chemicals activate adaptive immunity. Adaptive immunity then produces antibodies [18].
Figure 3.

Graphical classification of the immune system and immunity-related disorder.
Adaptive immunity is mediated by cell (T and B cells) and humeral (macromolecule-like antibodies in plasm cells of blood and immunoglobulin). It employs diverse antigen receptors that are not encoded in germline cells but rather de novo generated through DNA rearrangement mechanisms in the somatic immune tissues of mammalian organisms [18].
Immunity-related disorders are of two types: immunodeficiency and autoimmune disease (Figure 3). An immune response opposed to its healthy cells and tissues is called autoimmunity, leading to autoimmune diseases [29]. Some autoimmune diseases are rheumatoid arthritis, plaque psoriasis, and some inflammatory disease. Immunocompromised diseases are of two types: primary and secondary immunodeficiency diseases. A genetic defect of immune cells causes primary immunodeficiency disease (PIDD). There are around 130 types [22]. Secondary immunodeficiency diseases are caused by diseases or environmental factors, such as malnutrition, HIV, and medical treatment (e.g., chemotherapy). The most known secondary immunodeficiency diseases are AIDS, cancer, SARS, and COVID-19 [17, 20].
The mechanism of action of macrophages is degrading the pathogens with lysosome enzymes and peroxides or nitrogen monooxide. The enzyme breaks the cell wall and attacks the nucleus and ribosome, where protein synthesis occurs [30]. The mechanism of action of the antibody is either blocking the antigen from binding to its target, labeling a pathogen for destruction by macrophages or neutrophils, or activating the complement cascade [17].
5. Immunostimulant Drug and Plant Bioactive Molecules
Even nature is complete with bidirectional mutual interaction. Eventually, nature also needs improvement. One of the improvements is boosting the human immune system to fight disease. Humans rely on synthetic drugs and natural plant origin immunomodulators to do so.
Many substances that assist immunity progress are termed immunomodulators [31]. In other words, the biomolecules of biological origin or synthetic, capable of modulating, normalizing, suppressing, stimulating, or modifying any components of adaptive or innate immunity, decreasing the inflammatory responses through oxidation or alkylation are termed immunomodulators. Immunomodulators in clinical practice are mainly classified into immunosuppressants, immunostimulants, and immunoadjuvants (Figure 4). Immunoadjuvants are distinct immune mechanism stimulators added to vaccines to enhance the immune system. Immunostimulants enhance the immune system, while immunosuppressants reduce the immune system's efficacy [18, 20]. Therefore, in this section, synthetic immunomodulators with their limitations are discussed parallel to plant-derived bioactive immunomodulators. Tables 1–3 show drugs and plant-derived drugs used as immunomodulators.
Figure 4.

Classification of immunomodulators and immunity-enhancing methods.
Table 1.
Immunosuppressant drug, plant-derived bioactive, and microbe-derived drugs.
| Drugs | Use | Mode of action | Ref. |
|---|---|---|---|
| Immunosuppressant | |||
| (7) Cortisone and/or (8) prednisolone |
To treat rheumatoid arthritis disease (autoimmune disease) | Decreased leukocyte migration to sites of inflammation | [30] |
| (9) Azathioprine | Used in rheumatoid arthritis, granulomatosis with polyangiitis, Crohn's disease, ulcerative colitis, and antirejection | Inhibits purine synthesis and less DNA and RNA are produced for the synthesis of white blood cells, thus causing immunosuppression | [32] |
| (10) Leflunomide | Antirejection | Suppress T and B cell proliferations | [33, 34] |
| (11) Cyclophosphamide | Treat malignancies | Inhibit T and B cell proliferations | [35] |
| (12) 6-Marcaptopurine | Antiviral and anticancer | Interferon inducer | [36] |
|
| |||
| Plant-derived bioactive | |||
| (13) Resveratrol (grape) and (14) epigallocatechin-3-gallate (green tea) (polyphenols) | Anti-inflammatory, anticancer | By blocking NF-κB in LPS and PMA and blocking COX-2 | [20, 31] |
| (15) Quercetin (grapes) (flavonoids of polyphenol) | Antimutagenic, neuroprotective, antioxidative, anti-inflammatory, and anticancer | Inhibits the action of COX-2 by suppressing NF-κB, AP-1, and STAT-1 signaling in cytokines or LPS-activated macrophages | [20, 31] |
| (16) Colchicine and (17) capsaicin (chill paper) (both are alkaloid) |
Treat the familial Mediterranean fever and acute gout flares (FAD approved) | Inhibits activation and migration of neutrophils to sites of inflammation | [20, 31] |
| (18) Andrographolide (diterpenoid) | Treat cancer | Inhibits cancer cells growth by immunomodulatory effect and anti-inflammatory | [20, 31] |
|
| |||
| Microbe-derived drug | |||
| (19) Sirolimus (from bacteria) | Antirejection | Inhibits T lymphocyte activation and proliferation | [33, 34] |
| (20) Mycophenolate mofetil (from bacteria) | Antitumor | Inhibit IMDH | [33, 34] |
| (21) Cyclosporine (from soil fungus) (glycoprotein) | Antirejection | Suppress the production of immunoglobulins against foreign proteins in the new organ | [30] |
| (22) Tacrolimus (from bacteria) | Antirejection | Inhibit lymphocyte inhibition | [33, 34] |
Table 2.
Immunoadjuvant drug and plant-derived bioactive immunoadjuvant.
| Drugs | Use | Mode of action | Ref. |
|---|---|---|---|
| Immunoadjuvant | |||
| (1) Levamisole (Ergamisol) | Adjuvant therapy with 5-fluorouracil after surgical resection in patients with Duke's stage C colon cancer | Inducing B and T lymphocytes, monocytes, and macrophages | [37] |
|
| |||
| Plant-derived bioactive | |||
| (1) Pectic arabinogalactan (Cistanche deserticola) (polysaccharide) | Enhancing immune response of thymus gland by combining with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide | Enhancing effect of polysaccharides on murine thymus lymphocyte proliferation was related to its delivery of thymus intracellular calcium ions | [13] |
Table 3.
Low and high molecular weight natural products used as an immunomodulator.
| Example | Reference | |
|---|---|---|
| Low molecular weight compounds | ||
| (1) Alkaloid | Cocaine, vincristine | [20, 38] |
| (2) Terpenoids | Sesquiterpene lactones, diterpenes, and triterpenes | [20, 38] |
| (3) Phenolics | Flavonoids, coumarins, and quinones | [20, 38] |
|
| ||
| High molecular weight compounds | ||
| (1) Lectins | Concanavalin A | [20, 37, 38] |
| (2) Polysaccharides | Glucans, lentinans, and arabinogalactans | [20, 38] |
Immunostimulant drugs are drugs or plant-derived bioactives that enhance the immune system's efficacy with different modes of action, mostly oxidation reactions. Table 4 shows some immunostimulant drugs and plant-derived bioactive immunostimulants with their mechanism or mode of action.
Table 4.
Immunostimulant drug and plant-derived bioactive immunostimulant.
| Drugs | Use | Mode of action | Ref. |
|---|---|---|---|
| Immunostimulant | |||
| (1) (R)-Thalidomide or lenalidomide and pomalidomide | Treat multiple myeloma (cancer of plasma cell), treat rheumatoid arthritis and angiogenesis | Inhibit myeloma proliferation that reduces antibody production | [16, 37] |
| (2) Isoprinosine (inosiplex/Imunovir) | Treat herpes simplex infections, Epstein-Barr, and measles viruses | Enhance the levels of cytokines (IL-1, IL-2, and IFN-γ), a proliferation of lymphocytes, augmented active T cells, and induced T cell surface markers on prothymocytes | [37] |
| (3) Immunocynin (hemocyanin) | Treat urinary bladder cancer | Carry oxygen to the affected area | [37] |
| (4) Bestatin | Antitumor activity and also increase the antitumor activity of bleomycin and adriamycin | Binds to the cell surface of lymphocytes and macrophages and enhances adaptive immune responses | [37] |
|
| |||
| Plant bioactive | |||
| (5) Curcumin (turmeric) (polyphenol) | Antiproliferative, anticancer, proapoptotic, antiangiogenic, and antioxidant | Increase WBC count | [20, 39] |
| (6) Genistein (soy) (phytoestrogen) | Treat diabetes | Produce NO and PGE2, increase insulin resistance | [20, 31] |
There is also a so-called avridine, fluroquinone, polyribonucleotide immunostimulant drug. For the clinical purposes in addition to immunostimulant drugs or plant-derived drugs in Figure 5 and listed in Table 4, physicians use bacterial vaccines as immunization, carbohydrate (glucans, schizophyllan, scleroglucan, lentinan, station, bestatin, and acemannan), complimentary copolymer (polycytidylic acid), colony stimulant factors (glycoprotein stimulates WBC production, e.g., IL-3), interferons (soluble glycoprotein produced by host cell, e.g., IFNs-ἀ&β and IFNs-γ), interleukins, therapeutic and combination vaccine (e.g., Comvax and Twinrix), viral vaccine (Afluria), animal extracts (chitosan from shrimp), and plant extract (lectins and mitogens (phytohemagglutinin and concanavalin A)) as immunostimulant [16, 37].
Figure 5.

Immunostimulant drug and plant-derived bioactive immunostimulant [20].
The limitation of thalidomide (1) is that its S-form causes a birth defect. Isoprinosine (2) is a combination of inosine, acetamidobenzoic acid, and dimethylaminoisopropanol. Its disadvantages are minor CNS depressant, transient nausea, and an increased level of uric acid in serum and urine. Immunocynin (3) is a stable form of hemocyanin, a copper-containing protein found in mollusks and arthropods. It has poor drawbacks such as rare-mild fever. Bestatin (4) is an immunostimulant with low toxicity. It is a leucine aminopeptidase and aminopeptidase-B inhibitor [37].
6. Immunosuppressant Drug and Plant Bioactive Molecules
Immunosuppressants are drug that block the immune response and can be used to regulate the pathological immune response involved in organ transplants (prevent the graft-destructive immune response). Furthermore, these compounds can be used to alleviate diseases related to autoimmune disorders, hypersensitivity reactions (HR), and immunopathology (IP) or diseases originating from an autoimmune disorder [20]. Table 1 shows immunosuppressant drugs, plant-derived and microorganism-derived bioactive immunosuppressants with their use and mode of action. The structures are depicted in Figures 6–8.
Figure 6.

Figure 7.

Figure 8.

Microorganism-derived immunosuppressant bioactive drug [20, 31].
Azathioprine (9), an immunosuppressant agent, has the following side effects: medullar suppression, myalgia, pancreatitis, hepatitis, and dizziness [32]. The limitation of cyclosporine is its narrow therapeutic index. While low concentrations in the blood cause immunosuppression, high concentrations also cause kidney malfunction [30].
7. Immunoadjuvant Drug and Plant Bioactive Molecules
Immunoadjuvant is a chemical combined with an antigen for increasing immune response by stabilizing the antigen (Table 2). Immunoadjuvants enhance the efficacy of vaccines. For example, Freud's adjuvant is composed of inactivated and dried mycobacterium emulsified in mineral oil [20, 37].
8. Plant-Derived Natural Products as Immunomodulators
Medicinal plant extract as a food supplement and medicine is now not debatable. Even the US Food and Drug Administration (FDA) approved 1453 new chemical entities from natural products in 2013. In addition, WHO listed twenty-one thousand medicinal plants worldwide [8, 32]. The reason to rely on medicinal plant extract is more negligible side effects, less cost, and a multicomponent agent as opposed to the synthetic drug [10, 11]. Medicinal plants are used as antibacterial, anti-inflammatory, antioxidant, immunomodulators, antifungal, anthelmintic, and anticancer and to treat cardiovascular disease. Even the other era of natural product chemistry is hyphenating natural products with synthetic products. This combination effect is now a new research area in natural product chemistry and chemistry as a whole. Similarly, measuring the impact of mixed plant extract is on the way [32]. The other reason why natural product chemists should develop their full potential is because there are about 400,000 plant species in the world [20]. However, only 21,000 medicinal plants are recognized by the WHO [8].
8.1. Immunomodulator Plant
Immunomodulators are compounds that catalyze immune reactions [36]. The phytochemicals used as plant-derived immunostimulant drugs are polyphenols, flavonoids, diterpenoids, alkaloids, and phytoestrogens [20, 31]. Similarly, other phytochemicals found in plants have immunomodulatory activity but have not been approved yet. This includes pentacyclic triterpenes from Euphorbia microsciadia [32], thymoquinone from Nigella sativa [40], and triterpenoid from Scoparia dulcis Linn. [36]. On the other hand, for example, a study was done in 2000 in Iran; four medicinal plants, Silybum marianum, Matricaria chamomilla, Calendula officinalis, and Cichorium intybus, show immunomodulatory activity on their mitogenic activity though the study does not show the responsible phytochemical [41]. Like the Iranian study, there are many immunomodulatory activity studies done worldwide. Hence according to [20, 31, 42], there are 150 medicinal plants identified to have immunomodulatory activity. In the reference mentioned above, the plant part, responsible phytochemical, and mechanism of action are tabulated in detail. However, here, the pie chart (Figure 9) is extracted and constructed from the above references, and it shows the distribution of plants by a family with immunomodulatory activity.
Figure 9.

The distribution of plants by the family that has immunomodulatory activity.
Asteraceae accounts for 12% and is put in the first rank by offering 18 plant species. Similarly, Apiaceae (4.7%, 7 plants), Fabaceae (4%, 6 plants), Araliaceae (4%, 6 plants), Cucurbitaceae (3.3%, 5 plants), and Orobanchaceae (2.7%, 4 plants) take second up to sixth rank with their percent and plant offer shown in parenthesis. The rest of the families that give 1.3% offer two plants each from 16 families. The others which give 48% are only one family and give only one plant (72 plants). Similarly, generally from the plants studied so far regarding immunomodulatory activity, 40% of the plant species belong to the Asteraceae family [38].
As different scholars classify natural products, phytochemicals as an immunomodulator can be classified into two: low and high molecular weights. Moreover, Table 3 depicts this classification [20, 38]. The high molecular weight immunomodulator natural products are not presented in detail; however, some are mentioned as carbohydrate and plant extract proteins used as immunostimulants in Section 8.1 of this paper. Glucans and iridoid glycoside are two known examples of high molecular weight polysaccharides having immunomodulatory function. The other protein found in the plant is lectins. Lectins are carbohydrate-binding proteins [38].
Besides taking immunomodulators before and after infections occur, it is also good to follow the immunity-enhancing methods described in Figure 4 to be healthier. There are a total of eight immunity-enhancing strategies. Here, it should be clear that for clinical purposes, the immunity-enhancing method is three in type, while the general methods that every healthy man should follow are eight methods, including the clinical immunity-enhancing method (Figure 3). To get more insight into immunity-enhancing methods, refer to reference [16].
9. Mechanism of Action of Plant Phytochemicals as Immunomodulators
Figuratively, it is possible to categorize the mechanism or mode of action of the phytochemicals based on the method applied to measure their efficacy as in vitro and in vivo assays. In vivo assay is based on protecting host cells against pathogens while in vitro assay is of cellular and humoral immune molecular mechanisms. Therefore, the review's tool is based on in vitro and in vivo assays but does not detail pharmacodynamics and pharmacokinetics. In other words, immunomodulatory drug activity is not discussed in detail. Instead, it is more about plant-derived bioactive immunomodulators. However, as a sample, cyclophosphamide (CYC) (11) is one of the immunosuppressant drug modes of action due to its alkylating agent ability of DNA. CYC is a nitrogen mustard. Phosphoramide mustard is an active form of CYC that inhibits protein synthesis by alkylating DNA and cross-linking DNA at guanine N-7 sites (Figure 10). Indirectly, it kills resting and dividing lymphocytes. In a clinical test done on rheumatoid arthritis patients, the number of T cells and B cells decreased [34, 43, 44].
Figure 10.

Alkylation of DNA by nitrogen mustard (e.g., CYC).
The mechanism or mode of action based on target specificity is of two types, specific and nonspecific, in immunomodulator medicines or plant bioactives. Specific immunomodulator types are like vaccination which works for a specific antigen. In contrast, a nonspecific immunomodulator is not designed for specific antigens but rather activates both innate immunity and adaptive immunity (Figure 4) [20].
Plant bioactive immunomodulators' mechanism of action is generally based on activating and producing signal molecules (cytokines) of water-soluble glycoproteins. This includes colony-stimulating factors, interleukins, and interferon, produced by the host cell and can be obtain as vaccines and medicines [45]. These signal-sending molecules then activate the innate immune system (natural killer cell and macrophages) and adaptive immune system (cellular: antibody generation Ig and humoral: T and B cells). The immune system acts on antigen based on Toll-like receptor (TLR) protein and antigen interactions. Figure 11 shows a straightforward interaction of antibody, immunoglobulin, and antigen interaction with cell-cell recognition.
Figure 11.

Antibody immunoglobulin and antigen interaction with cell-cell recognition (H and L are heavy and light polypeptide chains, respectively).
So far in the discussion, one thing should be clear: immunomodulators are not anti-infective drugs or plant bioactive compounds. Instead, they increase the efficacy of anti-infective medicines like antibiotics by adding extra support from the host cell immune system. Of course, since some autoimmune diseases suppress the immune system, they can be considered anti-infective medicines. For example, for a disease called rheumatoid arthritis type which affects 0.6% of the US population [21], immunosuppressive drugs cortisone [30] and azathioprine [32] and natural product plant extract can be applied.
With the above idea in mind and referring to the low molecular weight class of chemicals, phenolic compounds, terpenoids, and alkaloids, the immunomodulatory mechanism of action is discussed by taking one specific compound from each class. Since structure-activity relations between different and within-class of a natural product are not often clear, it makes it difficult to classify the mechanism. However, induction of cytokines, the release of iNOS, and enhancement of phagocytosis are the most general mechanism shown by low molecular weight immunomodulator phytochemicals. Even though the mechanisms of the high molecular weight phytochemicals are limited to discuss here in this review, generally they exert their effect through stimulating macrophage function.
9.1. Phenolic and Flavonoid Compound, Resveratrol
Resveratrol (13) is derived from stilbene and phytoalexin. Grapevines, red wine, and peanuts are the main sources. The immunostimulant activities of resveratrol are due to the inhibition of the generation of iNOS in LPS- (lipopolysaccharide-) activated macrophages [38]. The enzyme nitric oxide synthases (NOS) catalyze the transformation of L-arginine to L-citrulline and nitric oxide (NO). This conversion occurs in the cytosol of cells (Figure 12). NO works as a cellular signaling molecule in response to cytokines and also attacks parasites, bacterial infection, and tumor growth since it is radical [38]. However, it is important to reduce NO production especially for cancer treatment in some cases. Chemically inducible NOS (iNOS) is a protein [46].
Figure 12.

iNOS inhibition by resveratrol in the cytosol of the cell.
In addition, according to [13], there are different flavonoids including apigenin (23), as shown in Figure 13, isolated from Terminalia arjuna plants that have immunomodulatory activity [13].
Figure 13.

Flavonoid immunomodulator.
9.2. Alkaloids
The two coca plant species Erythroxylum coca and Erythroxylum novogranatense are sources of a known alkaloid called cocaine. It affects the immune system by activating macrophage and splenocyte function by releasing IL-1a, IL-6, and TNF-a; splenocytes also release IFN-γ, IL-2, IL-4, IL-5, and IL-10 [38]. In addition, Figure 14 shows alkaloids that have immunomodulatory activity [13].
Figure 14.

Alkaloid immunomodulator.
9.3. Terpenoids, Andrographolide
The known diterpenoid found in the plant Andrographis paniculata is called andrographolide (18) (Figure 7). Its immunomodulatory activities have been observed in vitro, including the reduction of IL-12, TNF-α, PGE2, NO, COX-2, and iNOS in microglia and macrophages. Macrophage activity expressed by iNOS and COX-2 through LPS stimulation was inhibited by andrographolide [20, 31]. Figure 15 shows plants that are discussed in Sections 6 and 8.
Figure 15.

Immunomodulator of cultivated medicinal plants. (a) Turmeric. (b) Grape. (c) Chile paper. (d) Soybean.
10. Clinical Trials of Plant-Derived Molecules
As history tells, the use of immunostimulation therapy started in 1857 by Ferdinand Hoff by injecting milk or blood protein to treat malaria and lues [38]. Hence, the eight plant-derived immunomodulator bioactive compounds discussed in Section 4 of this review have already passed the clinical test and are approved. There are two immunostimulants, Curcumin (Curcuma longa) and Genistein (soy), and six immunosuppressants, resveratrol (grapevines, red wine, and peanuts), epigallocatechin-3-gallate (green tea Camellia sinensis), quercetin (tea, capers, red onions, broccoli, berries, grapevines, and apples), colchicine (Colchicum autumnale (family: Colchicaceae)), capsaicin (chili peppers (Capsicum species; Solanaceae)), and andrographolide (Andrographis paniculata) [31]. However, more work is still undergoing to get more immunomodulatory agents. For example, a combination of four medicinal plants by [47] was studied against immunomodulatory activity using in vivo test of cyclophosphamide-induced immunosuppressed mice. They found that this polyherbal medicine is effective. Figuratively, the polyherbal significantly (p < 0.01) enhanced the immune cells like natural killer (NK) cells, B cells, CD4 cells, and CD8 cells by 60%, 18%, 14%, and CD8 7%, respectively. Hence, several polyherbal medicines are found in the market, claiming to be immunomodulators. Vivartana, Chyawanprash, Brahma Rasayana, IM-133, and Septilin are some to mention that are formulated from the Indian traditional system of medicine, and they are clinically approved (Figure 16) [47].
Figure 16.

Medicinal plant extract sold in the market claimed to have immunomodulatory activity.
Septilin is a Hindu traditionally formulated medicine produced in India. It is a polyherbal drug. A preclinical test on Septilin by cyclophosphamide-induced immunosuppressed mice confirms its immunomodulatory activity [48]. Previously, these researchers [49] also did the cytotoxicity of Septilin against cisplatin- (Csp-) induced human breast adenocarcinoma (MCF-7) and normal human breast epithelial (MCF-10A) cell lines. They found that the polyherbal drug, Septilin, does not exert cytotoxicity on the normal human breast epithelial (MCF-10A) cell while it exerts its cytotoxicity on cisplatin-induced human breast adenocarcinoma (MCF-7) with a concentration of 5 μg/mL. This indicates that the polyherbal drug Septilin is safe to be used as a drug like the other plant source immunomodulatory drugs or phytochemicals.
In addition to polyphenols, terpenoids, and alkaloids, saponins are good immunostimulants. For example, cycloartane and oleanane-type unmistakably induced interleukin-2 activity [13]. Figure 17 shows some medicinal plant lists and images of the plant that have immunostimulant activity (1-5) and immunosuppressant activity (6).
Figure 17.

A list of immunomodulator medicinal plant.
11. Conclusion
Several plants' phytochemicals have been identified over the years for their immunomodulatory activity. Instead of commercial drugs, numerous illnesses can be alternatively treated by immunomodulation using medicinal plants. The discovery and isolation of more specific immunomodulatory agents from plant origin possess the potential to counteract the side effects and high cost of synthetic compounds. Taking plants and plant-derived immunomodulators, such as resveratrol meal supplements available from a pharmacy, has been popular in several nations recently. Many plant families are reported to have immunomodulatory activity; the Asteraceae family is an important one. Echinacea purpurea of this family is most known for its immunostimulating activity. Phenolic carboxylic acids, terpenoids, and alkaloids are the most prominently reported immune-active bioactive molecules. There are eight plant bioactive immunomodulators checked for clinical trials and found in the market. These are six immunosuppressants, resveratrol, epigallocatechin-3-gallate, quercetin, colchicine, capsaicin, andrographolide, and two immunostimulants, curcumin and genistein. This suggests that since our world is replete with therapeutic plants, considerable research into plant-derived immunomodulators will be necessary in the future to fully understand their mechanisms of action at the systemic, cellular, and molecular levels and extension to a broad-spectrum clinical trial.
Acknowledgments
We thank Addis Ababa Science and Technology University for the help in writing this review by providing the necessary opportunities. Also, we thank the Armauer Hansen Research Institute (AHRI), Addis Ababa, Ethiopia, for providing the microbiologist professional.
Conflicts of Interest
The authors declare that they have no competing interests.
Authors' Contributions
MZ and MG have drafted the review. AB, KKC, and RG prepared the different tables and figures required for the manuscript. RKB and MG provided guidance during the development of the idea and wrote and revised the manuscript. The authors read and approved the final manuscript.
References
- 1.Qu J., Huang Y., Lv X. Crisis of antimicrobial resistance in China: now and the future. Frontiers in Microbiology . 2019;10:p. 2240. doi: 10.3389/fmicb.2019.02240. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Housman G., Byler S., Heerboth S., et al. Drug resistance in cancer: an overview. Cancers . 2014;6(3):1769–1792. doi: 10.3390/cancers6031769. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Karaman R. Commonly Used Drugs-Uses, Side Effects, Bioavailability and Approaches to Improve It: Uses, Side Effects, Bioavailability & Approaches to Improve It . Nova Science Publishers, Incorporated; 2015. [Google Scholar]
- 4.Cassandra W. The drug-resistant bacteria that pose the greatest health threats. Nature . 2017;543:p. 15. doi: 10.1038/nature.2017.21550. [DOI] [PubMed] [Google Scholar]
- 5.Shaito A., Thuan D. T. B., Phu H. T., et al. Herbal medicine for cardiovascular diseases: efficacy, mechanisms, and safety. Frontiers in Pharmacology . 2020;11:p. 422. doi: 10.3389/fphar.2020.00422. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.World Health Organization. Global Status Report on Noncommunicable Diseases 2014 . World Health Organization; 2014. [Google Scholar]
- 7.Sofowora A., Ogunbodede E., Onayade A. The role and place of medicinal plants in the strategies for disease prevention. African Journal of Traditional, Complementary, and Alternative Medicines . 2013;10(5):210–229. doi: 10.4314/ajtcam.v10i5.2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Rahal A., Deb R., Latheef S. K., et al. Immunomodulatory and therapeutic potentials of herbal, traditional/indigenous and ethnoveterinary medicines. Pakistan Journal of Biological Sciences . 2012;15(16):754–774. doi: 10.3923/pjbs.2012.754.774. [DOI] [PubMed] [Google Scholar]
- 9.Ulriksen E. S., Butt H. S., Ohrvik A., et al. The discovery of novel immunomodulatory medicinal plants by combination of historical text reviews and immunological screening assays. Journal of Ethnopharmacology . 2022;296, article 115402 doi: 10.1016/j.jep.2022.115402. [DOI] [PubMed] [Google Scholar]
- 10.Djordjevic S. M. Aromatic and Medicinal Plants: Back to Nature . Intechopen; 2017. From medicinal plant raw material to herbal remedies; pp. 269–288. [DOI] [Google Scholar]
- 11.Fu B., Wang N., Tan H. Y., Li S., Cheung F., Feng Y. Multi-component herbal products in the prevention and treatment of chemotherapy-associated toxicity and side effects: a review on experimental and clinical evidences. Frontiers in Pharmacology . 2018;9:p. 1394. doi: 10.3389/fphar.2018.01394. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Asfaw T. B., Esho T. B., Bachheti A., Bachheti R. K., Pandey D. P., Husen A. Herbs, Shrubs, and Trees of Potential Medicinal Benefits . CRC Press; 2022. Exploring important herbs, shrubs, and trees for their traditional knowledge, chemical derivatives, and potential benefits; pp. 1–26. [DOI] [Google Scholar]
- 13.Kumar D., Arya V., Kaur R., Bhat Z. A., Gupta V. K., Kumar V. A review of immunomodulators in the Indian traditional health care system. Journal of Microbiology, Immunology and Infection . 2012;45(3):165–184. doi: 10.1016/j.jmii.2011.09.030. [DOI] [PubMed] [Google Scholar]
- 14.Shahbazi R., Sharifzad F., Bagheri R., Alsadi N., Yasavoli-Sharahi H., Matar C. Anti-inflammatory and immunomodulatory properties of fermented plant foods. Nutrients . 2021;13(5):p. 1516. doi: 10.3390/nu13051516. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.McKay S., Oranje P., Helin J., et al. Development of an affordable, sustainable and efficacious plant-based immunomodulatory food ingredient based on bell pepper or carrot RG-I pectic polysaccharides. Nutrients . 2021;13(3):p. 963. doi: 10.3390/nu13030963. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Paul S., El Bethel Hmar H. K. S. Strengthening immunity with immunostimulants: a. Current Trends in Pharmaceutical Research . 2020;7(1) [Google Scholar]
- 17.Virella G. Medical Immunology . CRC Press; 2019. [DOI] [Google Scholar]
- 18.Wen C.-C., Chen H.-M., Yang N.-S. Developing phytocompounds from medicinal plants as immunomodulators. Advances in Botanical Research . 2012;62:197–272. doi: 10.1016/B978-0-12-394591-4.00004-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Hoffmann D. Medical Herbalism: The Science and Practice of Herbal Medicine . Simon and Schuster; 2003. [Google Scholar]
- 20.Pal D., Nayak A. K. Bioactive Natural Products for Pharmaceutical Applications . Springer; 2021. [DOI] [Google Scholar]
- 21.Phathology, D.o. How common are autoimmune diseases? 2022. Januarry 2022, https://pathology.jhu.edu/autoimmune/prevalence.
- 22.Kobrynski L., Powell R. W., Bowen S. Prevalence and morbidity of primary immunodeficiency diseases, United States 2001–2007. Journal of Clinical Immunology . 2014;34(8):954–961. doi: 10.1007/s10875-014-0102-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Abolhassani H., Azizi G., Sharifi L., et al. Global systematic review of primary immunodeficiency registries. Expert Review of Clinical Immunology . 2020;16(7):717–732. doi: 10.1080/1744666X.2020.1801422. [DOI] [PubMed] [Google Scholar]
- 24.Schön C., Mödinger Y., Krüger F., Doebis C., Pischel I., Bonnländer B. A new high-quality elderberry plant extract exerts antiviral and immunomodulatory effects in vitro and ex vivo. Food and Agricultural Immunology . 2021;32(1):650–662. doi: 10.1080/09540105.2021.1978941. [DOI] [Google Scholar]
- 25.Schultz K. T., Grieder F. Structure and function of the immune system. Toxicologic Pathology . 1987;15(3):262–264. doi: 10.1177/019262338701500301. [DOI] [PubMed] [Google Scholar]
- 26.Chowdhury M. A., Hossain N., Kashem M. A., Shahid M. A., Alam A. Immune response in COVID-19: a review. Journal of Infection and Public Health . 2020;13(11):1619–1629. doi: 10.1016/j.jiph.2020.07.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Meagher M. Immune System Structure and Function . A. Christensen; 2004. [Google Scholar]
- 28.Warrington R., Watson W., Kim H. L., Antonetti F. R. An introduction to immunology and immunopathology. Allergy, Asthma & Clinical Immunology . 2011;7(S1):1–8. doi: 10.1186/1710-1492-7-S1-S1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Rajasekaran A., Venkatasubramanian G., Berk M., Debnath M. Mitochondrial dysfunction in schizophrenia: pathways, mechanisms and implications. Neuroscience & Biobehavioral Reviews . 2015;48:10–21. doi: 10.1016/j.neubiorev.2014.11.005. [DOI] [PubMed] [Google Scholar]
- 30.Stoker H. S. General, Organic, and Biological Chemistry . Cengage Learning; 2015. [Google Scholar]
- 31.Jantan I., Ahmad W., Bukhari S. N. A. Plant-derived immunomodulators: an insight on their preclinical evaluation and clinical trials. Frontiers in Plant Science . 2015;6:p. 655. doi: 10.3389/fpls.2015.00655. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Harun N. H., Septama A. W., Ahmad W. A. N. W., Suppian R. Immunomodulatory effects and structure-activity relationship of botanical pentacyclic triterpenes: a review. Chinese Herbal Medicines . 2020;12(2):118–124. doi: 10.1016/j.chmed.2019.11.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Halloran P. F. Immunosuppressive drugs for kidney transplantation. New England Journal of Medicine . 2004;351(26):2715–2729. doi: 10.1056/NEJMra033540. [DOI] [PubMed] [Google Scholar]
- 34.Gummert J. F., Ikonen T., Morris R. E. Newer immunosuppressive drugs. Journal of the American Society of Nephrology . 1999;10(6):1366–1380. doi: 10.1681/ASN.V1061366. [DOI] [PubMed] [Google Scholar]
- 35.Shukla S., Bajpai V. K., Kim M. Plants as potential sources of natural immunomodulators. Reviews in Environmental Science and Bio/Technology . 2014;13(1):17–33. doi: 10.1007/s11157-012-9303-x. [DOI] [Google Scholar]
- 36.Sharma K. R., Adhikari A., Jabeen A., et al. Immunomodulatory studies on triterpenoids from Scoparia dulcis Linn. Biochemical Pharmacology . 2015;4(4):p. 182. doi: 10.4172/2167-0501.1000182. [DOI] [Google Scholar]
- 37.Shahbazi S., Bolhassani A. Immunostimulants: types and functions. Journal of Medical Microbiology and Infectious Diseases . 2016;4(3):45–51. [Google Scholar]
- 38.Kayser O., Masihi K. N., Kiderlen A. F. Natural products and synthetic compounds as immunomodulators. Expert Review of Anti-Infective Therapy . 2003;1(2):319–335. doi: 10.1586/14787210.1.2.319. [DOI] [PubMed] [Google Scholar]
- 39.Antony S., Kuttan R., Kuttan G. Immunomodulatory activity of curcumin. Immunological Investigations . 1999;28(5-6):291–303. doi: 10.3109/08820139909062263. [DOI] [PubMed] [Google Scholar]
- 40.Majdalawieh A. F., Fayyad M. W. Immunomodulatory and anti-inflammatory action of Nigella sativa and thymoquinone: a comprehensive review. International Immunopharmacology . 2015;28(1):295–304. doi: 10.1016/j.intimp.2015.06.023. [DOI] [PubMed] [Google Scholar]
- 41.Amirghofran Z., Azadbakht M., Karimi M. H. Evaluation of the immunomodulatory effects of five herbal plants. Journal of Ethnopharmacology . 2000;72(1-2):167–172. doi: 10.1016/S0378-8741(00)00234-8. [DOI] [PubMed] [Google Scholar]
- 42.Nair A., Chattopadhyay D., Saha B. New Look to Phytomedicine . Elsevier; 2019. Plant-derived immunomodulators; pp. 435–499. [DOI] [Google Scholar]
- 43.Thomas S. S., Clements P. J., Furst D. E. Rheumatology . Elsevier; 2015. Immunosuppressives: cyclosporine, cyclophosphamide, azathioprine, mycophenolate mofetil; pp. 459–467. [DOI] [Google Scholar]
- 44.Kim K.-W., Roh J. K., Wee H. J., et al. Cancer Drug Discovery: Science and History . Springer; 2016. Alkylating Anticancer Drugs; pp. 71–94. [DOI] [Google Scholar]
- 45.Qiu Y., Su M., Liu L., Tang Y., Pan Y., Sun J. Clinical application of cytokines in cancer immunotherapy. Drug Design, Development and Therapy . 2021;Volume 15:2269–2287. doi: 10.2147/DDDT.S308578. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Cinelli M. A., do H. T., Miley G. P., Silverman R. B. Inducible nitric oxide synthase: regulation, structure, and inhibition. Medicinal Research Reviews . 2020;40(1):158–189. doi: 10.1002/med.21599. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Zahiruddin S., Parveen A., Khan W., et al. Metabolomic profiling and immunomodulatory activity of a polyherbal combination in cyclophosphamide-induced immunosuppressed mice. Frontiers in Pharmacology . 2022;12:p. 3547. doi: 10.3389/fphar.2021.647244. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Shenoy B. K. Septilin, a polyherbal formulation against the immunosuppression induced by cyclophosphamide and cisplatin in Swiss albino mice. Iranian Journal of Toxicology . 2022;16(1):17–26. doi: 10.32598/IJT.16.1.853.1. [DOI] [Google Scholar]
- 49.Shenoy K. B., Shruthi S., Vijayalaxmi K. K., Rao B. S. The modulatory effect of septilin on cytotoxicity of cisplatin in a human breast adenocarcinoma cell line. Indian Journal of Traditional Knowledge . 2020;19(2):435–441. doi: 10.56042/ijtk.v19i2.35361. [DOI] [Google Scholar]
